Rockefeller Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Rockefeller Capital Management's PBYI Position: Q3 2026 in Review
Rockefeller Capital Management held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 375 shares worth $3.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4453.
Rockefeller Capital Management first reported a position in PBYI in Q4 2018 and has held it in 18 quarters since. The position peaked at $524K in Q2 2021. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Rockefeller Capital Management held 375 shares of Puma Biotechnology worth $3.72K as of Q3 2026.
- Rockefeller Capital Management left its Puma Biotechnology share count unchanged in Q3 2026.
- Puma Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4453 holding.
- Rockefeller Capital Management first reported a position in Puma Biotechnology in Q4 2018 and has held it in 18 quarters since.
- Rockefeller Capital Management's Puma Biotechnology position peaked at $524K in Q2 2021.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.